Early research (Phase 1)Active Not RecruitingNCT06523153What this trial is testingThe Investigational Monoclonal Antibody, VYD2311, in Healthy ParticipantsWho this might be right forCOVID-19 Invivyd, Inc. 40
Early research (Phase 1)Study completedNCT04212091What this trial is testingEvaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult ParticipantsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 33
Testing effectiveness (Phase 2)Ended earlyNCT01532908What this trial is testingOpen Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis CWho this might be right forHepatitis C Infection MassBiologics 11
Post-approval studies (Phase 4)UnknownNCT04817917What this trial is testingSeroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang ProvinceWho this might be right forJapanese EncephalitisVaccine Preventable DiseaseVaccine Reaction Zhejiang Provincial Center for Disease Control and Prevention 712
Early research (Phase 1)Looking for participantsNCT06484335What this trial is testingRV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEVWho this might be right forHIV InfectionsPLWHART+1 more Henry M. Jackson Foundation for the Advancement of Military Medicine 48
Testing effectiveness (Phase 2)Ended earlyNCT04391309What this trial is testingCOVID-19 and Anti-CD14 Treatment TrialWho this might be right forCoronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) National Institute of Allergy and Infectious Diseases (NIAID) 49
Not applicableStudy completedNCT05580731What this trial is testingEvaluation Study of Dengue RDTsWho this might be right forDengue Fever Foundation for Innovative New Diagnostics, Switzerland 430
Early research (Phase 1)Study completedNCT02960581What this trial is testingSafety, PK and Antiviral Activity of PGT121 Monoclonal Antibody in HIV-uninfected and HIV-infected AdultsWho this might be right forHIV Infection International AIDS Vaccine Initiative 48
Not applicableStudy completedNCT04380896What this trial is testingCOVID-19 Staff Testing of Antibody Responses Study (Co-Stars)Who this might be right forSARS-CoV-2 Infection Great Ormond Street Hospital for Children NHS Foundation Trust 3,502
Not applicableActive Not RecruitingNCT06357806What this trial is testingThe Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB PatientsWho this might be right forChronic Hepatitis B Beijing 302 Hospital 45
Not applicableUnknownNCT05109585What this trial is testingDeterminants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination StudyWho this might be right forSARS-CoV2 InfectionSARS-CoV2 Antibodies Collegium Medicum w Bydgoszczy 1,000
Testing effectiveness (Phase 2)UnknownNCT03625934What this trial is testingStudy to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001Who this might be right forHepatitis B Viravaxx AG 84
Not applicableStudy completedNCT04426006What this trial is testingSerological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 PandemicWho this might be right forSars-CoV2Serum; Disease Institut Bergonié 526
Large-scale testing (Phase 3)Ended earlyNCT01288131What this trial is testingStudy of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) TreatmentWho this might be right forAnti-r-HuEpo Associated PRCA Subjects Chulalongkorn University 8
Not applicableUnknownNCT05827939What this trial is testingAssociation of Phenotypic Age and Antibody Titers Among SARS-Co-V2 Infected Patients and Vaccinated GroupsWho this might be right forCOVID-19 Chang Gung Memorial Hospital 330
Not applicableLooking for participantsNCT05017142What this trial is testingSwiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)Who this might be right forOptic NeuritisTransverse MyelitisAcute Disseminated Encephalomyelitis+15 more University of Bern 500
Post-approval studies (Phase 4)Study completedNCT00503529What this trial is testingTBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)Who this might be right forEncephalitis, Tick-Borne Pfizer 314
Not applicableStudy completedNCT04808986What this trial is testingSeroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household ContactsWho this might be right forCovid19 Institut National de la Santé Et de la Recherche Médicale, France 2,817
Early research (Phase 1)Study completedNCT05685953What this trial is testingA Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 VaccineWho this might be right forCOVID-19 Respiratory InfectionCOVID-19 Vaccine Adverse Reaction Matti Sällberg 16
Not applicableUnknownNCT04743388What this trial is testingStudy of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune SystemWho this might be right forCOVID-19Healthy VolunteersChronic Disease+2 more National and Kapodistrian University of Athens 600